查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750699

非小細胞肺癌治療市場規模、佔有率、趨勢分析報告：按類型、治療方法、分銷管道、地區和細分市場預測，2025 年至 2030 年

Non-small Cell Lung Cancer Therapeutics Market Size, Share & Trends Analysis Report By Type, By Treatment, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

非小細胞肺癌治療市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球非小細胞肺癌治療市場規模預計到2030年將達到438.9億美元，2025年至2030年期間的複合年成長率為12.71%。

預計非小細胞肺癌 (NSCLC) 市場將在預測期內顯著成長，這得益於市場參與企業在肺癌治療研發方面的大量投資、豐富的產品線以及預測期內藥物滲透率的提高。

預計在預測期內，多種藥物在不同地區的上市將推動市場發展。例如，2016年10月，美國食品藥物管理局（FDA）授予基因泰克公司（Genentech）開發的用於治療ALK陽性非小細胞肺癌（NSCLC）的第一線藥物Alecensa（Alectinib）突破性療法認定。該藥物已在美國、日本、加拿大、香港、韓國、科威特和以色列核准。

預測期內，強大的非小細胞肺癌治療產品線將推動市場發展。百時美施貴寶公司、Orion Corporation、默克公司、阿斯特捷利康、羅氏公司和輝瑞公司均已在其產品線中擁有關鍵分子藥物。

非小細胞肺癌治療市場報告重點

  • 由於消費菸草和其他吸菸產品的人口不斷增加，腺癌部分佔據了市場的主導地位，到 2024 年將佔據 43.39% 的佔有率。預計鱗狀細胞癌 (SCC) 部分在預測期內的複合年成長率最快。
  • 標靶治療領域佔據主導地位，2024 年的市佔率為 50.66%。預計免疫治療領域在預測期內將以顯著的複合年成長率成長。
  • 醫院藥房部門佔據市場主導地位，2024 年的佔有率為 66.89%。由於可供尋求治療 NSCLC 的患者使用的經監管部門核准的藥物越來越多，預計藥局和零售藥局部門在預測期內將呈現顯著的複合年成長率。
  • 北美非小細胞肺癌 (NSCLC) 治療產業佔據全球市場佔有率為 35.41%。亞太地區非小細胞肺癌 (NSCLC) 治療行業正在經歷快速成長，這得益於肺癌發病率上升、政府對腫瘤醫療保健的投資以及區域夥伴關係的不斷加強，以獲得更廣泛的生技藥品和標靶藥物。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 非小細胞肺癌治療市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 非小細胞肺癌治療市場分析工具
    • 波特分析
    • PESTEL分析
  • 管道分析
  • 定價分析

第4章 非小細胞肺癌治療市場：按類型估計和趨勢分析

  • 細分儀表板
  • 非小細胞肺癌治療市場佔有率（按類型分類）（2024 年和 2030 年，百萬美元）
  • 鱗狀細胞癌
  • 大細胞癌
  • 腺癌
  • 其他

第5章非小細胞肺癌治療市場：治療方法的估計和趨勢分析

  • 細分儀表板
  • 非小細胞肺癌治療市場佔有率（按治療方法）（2024 年和 2030 年，百萬美元）
  • 化療
  • 標靶治療
  • 免疫療法
  • 其他

第6章非小細胞肺癌治療市場：按分銷管道的估計和趨勢分析

  • 細分儀表板
  • 非小細胞肺癌治療市場佔有率（2024 年和 2030 年，百萬美元）
  • 醫院藥房
  • 藥局和零售藥局
  • 網路藥局

第7章非小細胞肺癌治療市場：按地區估計和趨勢分析

  • 非小細胞肺癌治療市場佔有率（2024 年和 2030 年，百萬美元）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Pfizer Inc.
    • GSK plc
    • Novartis AG
    • Bayer AG
    • Eli Lilly and Company
    • Merck & Co., Inc
Product Code: GVR-1-68038-703-2

Non-small Cell Lung Cancer Therapeutics Market Growth & Trends:

The global non-small cell lung cancer therapeutics market size is expected to reach USD 43.89 billion by 2030, registering a CAGR of 12.71% from 2025 to 2030, according to a new report by Grand View Research, Inc. The non-small cell cancer therapeutics (NSCLC) market is anticipated to witness significant growth during the forecast period. This can be attributed to the high investment by market players in the research and development of lung cancer therapy, presence of a rich pipeline, and increasing penetration of drugs during the forecast period.

Introduction of several drugs in various geographical regions is likely to drive the market during the forecast period. For instance, in October 2016, the FDA granted Breakthrough Therapy Designation to Alecensa (alectinib), a drug developed by Genentech to treat ALK-positive NSCLC as a first-line treatment. The drug has been approved in the U.S., Japan, Canada, Hong Kong, South Korea, Kuwait, and Israel.

Presence of a strong pipeline of drugs for non-small cell lung cancer helps propel the market during the forecast period. Bristol-Myers Squibb Company, Orion Corporation, Merck KGaA, AstraZeneca, F. Hoffmann-La Roche Ltd, and Pfizer, Inc. have major molecules in the pipeline.

Non-small Cell Lung Cancer Therapeutics Market Report Highlights:

  • The adenocarcinoma segment dominated the market in 2024 with a share of 43.39% in 2024 due to an increase in the population consuming tobacco and other products for smoking. The squamous cell carcinoma (SCC) segment is anticipated to witness the fastest CAGR over the forecast period.
  • The targeted therapy segment dominated the market in 2024 with a share of 50.66% in 2024. The immunotherapy segment is expected to grow at a significant CAGR over the forecast period.
  • The hospital pharmacy segment dominated the market with a share of 66.89% in 2024. The drug store and retail pharmacy segment is anticipated to witness a significant CAGR over the forecast period, owing to the increased availability of regulatory-approved drugs for consumption by patients seeking to cure NSCLC.
  • North America Non-small Cell Lung Cancer (NSCLC) therapeutics industry dominated globally with a market share of 35.41% in 2024. The Non-small Cell Lung Cancer (NSCLC) therapeutics industry in Asia Pacific is witnessing rapid growth fueled by rising lung cancer incidence, government investment in oncology care, and growing regional partnerships to expand access to biologics and targeted drugs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Non-small cell lung cancer therapeutics market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Non-small Cell Lung Cancer Therapeutics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape
  • 3.5. Pipeline Analysis
  • 3.6. Pricing Analysis

Chapter 4. Non-small Cell Lung Cancer Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Non-small Cell Lung Cancer Therapeutics Market: Type Movement Analysis, USD Million, 2024 & 2030
  • 4.3. Squamous Cell Carcinoma
    • 4.3.1. Squamous Cell Carcinoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Large Cell Carcinoma
  • 4.5. Large Cell Carcinoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Adenocarcinoma
    • 4.6.1. Adenocarcinoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Non-small Cell Lung Cancer Therapeutics Market: Treatment Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Non-small Cell Lung Cancer Therapeutics Market: Treatment Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Chemotherapy
    • 5.3.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Targeted Therapy
    • 5.4.1. Targeted Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Immunotherapy
    • 5.5.1. Immunotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Non-small Cell Lung Cancer Therapeutics Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Non-small Cell Lung Cancer Therapeutics Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Hospital Pharmacy
    • 6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Drug Store and Retail Pharmacy
    • 6.4.1. Drug Store and Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Online Pharmacy
    • 6.5.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Non-small Cell Lung Cancer Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Non-small Cell Lung Cancer Therapeutics Market Share, By Region, 2024 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Non-small Cell Lung Cancer Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. F. Hoffmann-La Roche Ltd
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Mylan N.V.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Teva Pharmaceutical Industries Ltd.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Sanofi
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Pfizer Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. GSK plc
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Novartis AG
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Bayer AG
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Eli Lilly and Company
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Merck & Co., Inc
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of abbreviations
  • Table 3. North America Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 4. North America Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 5. North America Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 6. North America Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7. US Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 8. US Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 9. US Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 10. Canada Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 12. Canada Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 15. Mexico Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 16. Europe Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 17. Europe Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 18. Europe Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 19. Europe Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20. Germany Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 21. Germany Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 22. Germany Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23. UK Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 24. UK Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 25. UK Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26. France Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 27. France Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 28. France Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 29. Italy Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 30. Italy Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 31. Italy Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32. Spain Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 33. Spain Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 34. Spain Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35. Denmark Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 36. Denmark Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 37. Denmark Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38. Sweden Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 39. Sweden Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 40. Sweden Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41. Norway Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 42. Norway Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Norway Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48. China Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 49. China Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 50. China Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 51. Japan Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 52. Japan Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 53. Japan Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54. India Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 55. India Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 56. India Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 57. South Korea Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 58. South Korea Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 59. South Korea Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 60. Australia Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 61. Australia Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 62. Australia Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63. Thailand Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 64. Thailand Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. Thailand Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 66. Latin America Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 67. Latin America Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 68. Latin America Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 69. Latin America Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 70. Brazil Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 71. Brazil Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 72. Brazil Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 73. Argentina Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 74. Argentina Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 75. Argentina Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 76. MEA Non-small Cell Lung Cancer Therapeutics Market, by region, 2018 - 2030 (USD Million)
  • Table 77. MEA Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 78. MEA Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 79. MEA Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 80. South Africa Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 81. South Africa Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 82. South Africa Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 86. UAE Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 87. UAE Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 88. UAE Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 89. Kuwait Non-small Cell Lung Cancer Therapeutics Market, by type, 2018 - 2030 (USD Million)
  • Table 90. Kuwait Non-small Cell Lung Cancer Therapeutics Market, by treatment, 2018 - 2030 (USD Million)
  • Table 91. Kuwait Non-small Cell Lung Cancer Therapeutics Market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Non-small Cell Lung Cancer Therapeutics, Market Segmentation
  • Fig. 9 Market Snapshot, 2024
  • Fig. 10 Market Trends & Outlook
  • Fig. 11 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Non-small Cell Lung Cancer Therapeutics Market: Type Movement Analysis
  • Fig. 16 Global Non-small Cell Lung Cancer Therapeutics Market: Treatment Movement Analysis
  • Fig. 17 Global Non-small Cell Lung Cancer Therapeutics Market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 18 Regional Marketplace: Key Takeaways
  • Fig. 19 Regional Outlook, 2024 & 2030
  • Fig. 20 Global Non-small Cell Lung Cancer Therapeutics Market: Region Movement Analysis
  • Fig. 21 North America Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 24 Mexico Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 25 Europe Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 27 UK Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 28 France Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 29 Italy Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 30 Spain Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 31 Denmark Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 32 Sweden Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 33 Norway Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 36 China Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 37 India Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Thailand Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 40 South Korea Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 41 Latin America Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 42 Brazil Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Argentina Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Middle East and Africa Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 45 South Africa Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 47 UAE Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Kuwait Non-small Cell Lung Cancer Therapeutics Market, 2018 - 2030 (USD Million)